NEXGEL
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Pennsylvania, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2150 Cabot Blvd W Ste B, Langhorne, Penn...Phone Number
(215) 702-8550Website
www.nexgel.comRevenue
$11.3 MillionStock Symbol
NXGLIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About NEXGEL
NEXGEL is a healthcare and materials science company that develops and manufactures advanced hydrogel-based patches and transdermal delivery systems used in wound care, cosmetics, and over-the-counter medical applications. The company specializes in electron-beam cross-linked hydrogel technology designed to deliver active ingredients gently to the skin without traditional chemical adhesives. Its products are used across medical, cosmetic, and consumer health markets, focusing on skin-friendly, high-water-content materials for therapeutic and commercial applications.Explore more
NEXGEL Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NEXGEL your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NEXGEL is spiking on competitors!
Earning: See what the market has to say on NEXGEL recently announced quarterly report
Product Launch: Get notified when NEXGEL launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if NEXGEL has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if NEXGEL had a recent Job posting/layoffs
Funding: Get notified immidiatlly once NEXGEL has new funding data
Congratulate Masked Content for being promoted to Masked Content at NEXGEL
NEXGEL, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at NEXGEL
Find 2 more new buyers
Compare Similar Companies to NEXGEL
Compare insights from companies similar to NEXGEL, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NEXGEL is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NEXGEL is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NEXGEL.
NEXGEL financials insights
Gather financial insights about NEXGEL, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$127K
2022
Stock Offering
$14.2M
2026
Stock/Share Issuance
$1.2M
NEXGEL Tech Stack
A closer look at the technologies used by NEXGEL
See more technologies
Most Recent Scoops
Event
will be hosting its first Cadaver Lab event in mid-July. The event is designed to engage practitioners and gather feedback to support the development of a comprehensive product suite for regenerative medicine solutions.
Events, Product Development, Medical Research
Project
NEXGEL has partnered with Fountainhead Life Sciences, whose Sequence division serves as a backup manufacturer for skin substitute products, providing supply chain redundancy and competitive pricing with the potential to consolidate all manufacturing operations over time.
Logistics / Supply Chain, Manufacturing Operations
Project
NEXGEL has announced the launch of its ocular program on August 1st, targeting a range of eye healing applications including ocular cancer, scratched corneas, and other related conditions.
Medical Research
Partnership
NEXGEL has partnered with STADA through its Histosol product line, with five additional STADA products expected to be introduced during the current and upcoming quarter.
Partnership
Project
NEXGEL News & Media
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
The study concluded that NEXGEL’s hydrogel patch significantly reduced laser plume generation and exposure during laser hair removal and the patch was associated with greater hair reduction and reduced pain compared to the controlNexGel Raises $1.21 Million Via Convertible Notes and Warrants; $0.60 Conversion, $0.80 Exercise
NexGel secured $1.21 million in a private placement of unsecured convertible promissory notes and warrants with accredited investors, setting an initial note conversion price of $0.60 per share and a warrant exercise price of $0.80 for 1,008,334 shares, with warrants expiring five years from issuan…NEXGEL To Report First Quarter 2026 Financial Results on May 15th
Management Will Host a Conference Call at 12:00 P.M. ET on the Same DayNEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience™, to Board of Directors
Sequence LifeScienceTM Led Financing to Close on Acquisition of Celularity with Strategic Investment of $5.5 Million
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NEXGEL
Sign Up For FreeTo access detailed company insights
NEXGEL is a healthcare and materials science company that develops and manufactures advanced hydrogel-based patches and transdermal delivery systems used in wound care, cosmetics, and over-the-counter medical applications. The company specializes in electron-beam cross-linked hydrogel technology designed to deliver active ingredients gently to the... Read More
